BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6163684)

  • 21. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
    Piver MS; Lele S; Barlow JJ
    Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
    Seski JC; Edwards CL; Gershenson DM; Copeland LJ
    Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical strategy for peritoneal carcinosis of ovarian origin].
    Michel G; Morice P; Castaigne D; Lanoux P
    J Chir (Paris); 1997 Nov; 134(5-6):229-32. PubMed ID: 9772978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian cancer associated with pregnancy.
    Chung A; Birnbaum SJ
    Obstet Gynecol; 1973 Feb; 41(2):211-4. PubMed ID: 4684204
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiences with the cytostatic treatment of malignant ovarian tumors].
    Ferkó S; Gál I; Szönyi I
    Acta Chir Acad Sci Hung; 1967; 8(1):75-87. PubMed ID: 5598288
    [No Abstract]   [Full Text] [Related]  

  • 26. [Metastatic ovarian tumor on both sides as acute puerperium complication].
    Holzer E; Haigermoser A; Pickel H
    Gynakol Rundsch; 1976; 16(3):211-6. PubMed ID: 191334
    [No Abstract]   [Full Text] [Related]  

  • 27. [Contribution to the chemotherapy of ovarian neoplasms].
    Kwaśniewska-Rokicińska ; Jopkiewicz Z
    Pol Tyg Lek; 1967 Jul; 22(20):1153-4. PubMed ID: 4168670
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of ovarian carcinoma. Current concepts and future prospects (first of two parts).
    Tobias JS; Griffiths CT
    N Engl J Med; 1976 Apr; 294(15):818-22. PubMed ID: 765825
    [No Abstract]   [Full Text] [Related]  

  • 29. [Second-look operations in malignant ovarian cancers].
    Tsunawaki A; Yakushiji M; Matsukuma T; Nishimura H; Kato T
    Gan No Rinsho; 1983 Aug; 29(10):1286-90. PubMed ID: 6632208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experiences with cyclophosphamide and x-ray combination therapy in ovarian neoplasms].
    Schultze H; Weise W
    Radiobiol Radiother (Berl); 1971; 12(2):173-81. PubMed ID: 4110089
    [No Abstract]   [Full Text] [Related]  

  • 33. X-rays treatment of advanced cases of ovarian cancer.
    Kielbińska S; Piatkowski Z
    Pol Med J; 1968; 7(1):176-81. PubMed ID: 4172091
    [No Abstract]   [Full Text] [Related]  

  • 34. [The importance of second-look surgery following radio-chemotherapy for advanced ovarian cancer (author's transl)].
    Janisch H; Gerstner G
    Wien Klin Wochenschr; 1980 Apr; 92(9):310-4. PubMed ID: 6930762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
    Inagaki J; Ogawa M; Horikoshi N; Ezaki K; Inoue K; Aiba K; Komyo M; Miyamoto H; Ikeda K; Kubo H
    Gan No Rinsho; 1983 Aug; 29(10):1291-5. PubMed ID: 6685195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor reduction by second-look laparotomy following combined radiochemotherapy in advanced ovarian carcinoma].
    Szalay S; Janisch H; Breitenecker G; Szepesi T
    Gynakol Rundsch; 1982; 22(2):150-3. PubMed ID: 7201947
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-term effects of chemotherapy-surgery-chemotherapy regimen on clinically inoperable advanced ovarian cancer.
    Feng Y; Sun T
    Chin Med J (Engl); 1998 Aug; 111(8):722-5. PubMed ID: 11245027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic results of malignant ovarian tumor].
    Fukazawa I; Masubuchi S; Okajima H; Fukuda K; Hayashi K; Yokosuka K; Miyata R; Masubuchi K
    Gan No Rinsho; 1984 Jun; 30(7):819-26. PubMed ID: 6431145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
    Naumann R
    Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy of ovarian cancer].
    Pickel H; Lahousen M
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():77-83. PubMed ID: 6260600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.